Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter Mortimer
Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Chemotherapy of Metastatic Neuroendocrine Tumors With Aranose in Monoregimen and in Combination With Capecitabine and Temozolomide.
Malignant tumours
Chemotherapy-Associated Steatohepatitis With Temozolomide and Dexamethasone
Canadian Journal of Neurological Sciences
Medicine
Neurology
A Phase I/Ii Study of Lomustine and Temozolomide in Patients With Cerebral Metastases From Malignant Melanoma
British Journal of Cancer
Cancer Research
Oncology
The Addition of Cixutumumab or Temozolomide to Intensive Multiagent Chemotherapy Is Feasible but Does Not Improve Outcome for Patients With Metastatic Rhabdomyosarcoma
Cancer
Cancer Research
Oncology
Dasatinib-Induced Autophagy Is Enhanced in Combination With Temozolomide in Glioma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Short-Course Radiation Plus Temozolomide in Elderly Patients With Glioblastoma
New England Journal of Medicine
Medicine
Pcn220 - End-Of-Life Care in Patients With Metastatic Cutaneous Melanoma in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Phase II, Multicenter, Randomized Trial of Docetaxel Plus Prednisone With or Without Cediranib in Men With Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer
Oncologist
Cancer Research
Medicine
Oncology
Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined With Poly (ADP-Ribose) Polymerase Inhibitor
Molecular Pharmacology
Molecular Medicine
Pharmacology
